Mateusz Wilk, MD

Haematology and Internal Medicine Clinical Department, University Hospital Kraków, Poland

Poster(s):

• 1406 - Venetoclax and obinutuzumab in first-line treatment of unfit patients with CLL – real-life data analysis of the Polish Adult Leukemia Group